Furthermore, a significant decrease of miR-26b-5p expression was observed in IL-6-treated GC cells, and STAT3 knockdown attenuated IL-6-stimulated miR-26b-5p reduction, indicating a negative regulation of IL-6/STAT3 and miR-26b-5p. This evidence concerns the gene IL6 and gastric cancer.